<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04609527</url>
  </required_header>
  <id_info>
    <org_study_id>Placenta Accreta</org_study_id>
    <nct_id>NCT04609527</nct_id>
  </id_info>
  <brief_title>Management of Placenta Accreta Spectrum</brief_title>
  <official_title>Management of Placenta Accreta Spectrum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      placenta accreta spectrum is group of disorders which have a depate about the best way of&#xD;
      management. this is a descriptive study about the best techniques to reduce morbidity and&#xD;
      mortalities related to it.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      placenta accreta spectrum is group of disorders which have a depate about the best way of&#xD;
      management. this is a descriptive study about the best techniques to reduce morbidity and&#xD;
      mortalities related to it.&#xD;
&#xD;
        1. surgical management of placenta accreta&#xD;
&#xD;
        2. short term follow up to the outcomes&#xD;
&#xD;
        3. long term follow up&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 16, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All women with placenta praevia and previous scar in the uterus. Surgical management and follow up will be defined</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Failure of the novel conservative management</measure>
    <time_frame>3 hours</time_frame>
    <description>Need to do peripartum hysterectomy or patient death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated amount of blood loss</measure>
    <time_frame>6 hours</time_frame>
    <description>The estimated amount of blood loss during and after surgery</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Placenta Previa</condition>
  <condition>Placenta Accreta</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Management of placenta accreta spectrum</intervention_name>
    <description>Conservative and radical (hysterectomy) treatment of placenta accreta. Follow up to the patients to detect the impact of treatment imposed A novel technique which early identification and repait of uterine wall defects resulted from invasion of the uterine wall by the placenta.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All placenta accreta e high possibility of placenta accrete&#xD;
&#xD;
          -  consent&#xD;
&#xD;
          -  easy follow up visits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  bleeding tendency&#xD;
&#xD;
          -  associated medical disorder hypertension, diabetes, preeclapsia..&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Osama Abdalmageed</last_name>
    <phone>01012234876</phone>
    <email>drosamast@aun.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>maha said</last_name>
    <phone>01013464458</phone>
    <email>drmahasaid2014@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Osama Abdalmageed</name>
      <address>
        <city>Assiut</city>
        <state>Non-US/Non-Canadian</state>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama Abdalmageed</last_name>
      <phone>1007972027</phone>
      <email>drosamast1981@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdalmageed</last_name>
      <phone>1007972027</phone>
      <email>drosamast@yahoo.com.au</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>October 30, 2020</last_update_submitted>
  <last_update_submitted_qc>October 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Osama Saber Thabet Abdalmageed</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>placenta</keyword>
  <keyword>accreta</keyword>
  <keyword>praevia</keyword>
  <keyword>hyterectomy</keyword>
  <keyword>PPH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Previa</mesh_term>
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

